![](images/graphics/blank.gif)
Protein tyrosine kinase
-
Combination therapy is the primary treatment for unresectable hepatocellular carcinoma (u-HCC). The hepatic functional reserve is also critical in the treatment of HCC. In this study, u-HCC was treated with combined hepatic arterial infusion chemotherapy (HAIC), tyrosine kinase inhibitors (TKIs), and programmed cell death protein-1 (PD-1) inhibitors to analyze the therapeutic response, progression-free survival (PFS), and safety.
10p
vishanshan
27-06-2024
2
1
Download
-
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract. Acquired functional mutations in the tyrosine-protein kinase growth factor receptor proto-oncogene (KIT) and platelet-derived growth factor-alpha gene lead to increased tyrosine kinase activity, which is considered a key factor in the pathogenesis of GIST.
14p
vikoch
27-06-2024
1
1
Download
-
Chronic myeloid leukemia (CML) is effectively treated with tyrosine kinase inhibitors (TKIs), targeting the BCR::ABL1 oncoprotein. Still, resistance to therapy, relapse after treatment discontinuation, and side effects remain significant issues of long-term TKI treatment. Preliminary studies have shown that targeting oxidative phosphorylation (oxPhos) and the unfolded protein response (UPR) are promising therapeutic approaches to complement CML treatment.
12p
vileonardodavinci
23-12-2023
2
2
Download
-
Fatty acid synthase (FASN) expression is associated with a more aggressive breast cancer phenotype and is regulated downstream of receptor tyrosine kinase (RTK) signaling pathways. Recently, post transcriptional regulation of lipogenic transcripts have been demonstrated as being mediated downstream of serine-arginine rich protein kinase 2 (SRPK2), which acts to phosphorylate serine-arginine rich splicing factors (SRSFs), resulting in RNA binding and various RNA regulatory processes.
13p
vialfrednobel
23-12-2023
5
3
Download
-
Gen GIGYF2 (GRB10 Interacting GYF Protein 2 – Protein GYF2 tương tác GRB10) mã hóa ra protein cùng tên đóng vai trò quan trọng quá trình điều hòa tín hiệu của các thụ thể tyrosin kinase trên các tế bào thần kinh. Bài viết Đột biến gen GIGYF2 ở người bệnh mắc bệnh Parkinson trình bày xác định đột biến của gen GIGYF2 ở bệnh nhân Parkinson bằng phương pháp giải trình tự gen Sanger.
7p
vishekhar
01-11-2023
2
0
Download
-
FMS-like tyrosine kinase 3 (FLT3) hầu như chỉ biểu hiện trên các tế bào gốc máu và đóng vai trò quan trọng trong quá tồn tại, tăng sinh và phát triển của nhóm tế bào này. Những bất thường xảy ra liên quan đến tăng cường biểu hiện protein FLT3 hoặc đột biến gen FLT3 có thể là nguyên nhân phát sinh bệnh ung thư bạch cầu dòng tủy cấp tính (AML) và thường gắn liền với tiên lượng xấu. Một số các liệu pháp điều trị hướng đích FLT3 và tình hình nghiên cứu, ứng dụng trong điều trị lâm sàng cũng được cập nhật trong bài viết này.
10p
kimphuong1126
07-09-2023
6
2
Download
-
Bài viết "Vai trò của FMS-like tyrosine kinase 3 (FLT3) trong phát sinh bệnh bạch cầu dòng tủy cấp tính" tìm hiểu về các liệu pháp điều trị hướng đích FLT3 và tình hình nghiên cứu, ứng dụng trong điều trị lâm sàng.
10p
kimphuong17
01-08-2023
10
3
Download
-
Midostaurin combined with chemotherapy is currently used to treat newly diagnosed acute myeloid leukemia (AML) patients with FMS-like tyrosine kinase 3 (FLT3)-mutations. However, midostaurin acts as an antagonist to some chemotherapeutic agents in leukemia cell lines without FLT3 mutations.
14p
vikolindagrabar
27-07-2022
4
2
Download
-
Direct and indirect effects of radiofrequency ablation (RFA) on tumor microenvironment of the liver tumor have been noted, which was reported to be related to a variety of tyrosine-protein kinase or cytokinetic path‑ way, but have not been thoroughly investigated and conclusive.
11p
visusanwojcicki
28-06-2022
9
2
Download
-
Tropomyosin receptor kinase (TRK) fusion proteins resulting from neurotrophic tyrosine receptor kinase (NTRK) gene fusions are rare primary oncogenic drivers in a wide array of tumors. Larotrectinib is a first-in-class, highly selective, central nervous system-active TRK inhibitor approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and over 40 countries for the treatment of TRK fusion solid tumors in adult and pediatric patients.
11p
visusanwojcicki
28-06-2022
9
2
Download
-
Acute lung injury (ALI) is associated with high mortality due to the lack of effective therapeutic strategies. Mechanical ventilation itself can cause ventilator-induced lung injury. Pulmonary vascular barrier function, regulated in part by Src kinase-dependent phosphorylation of caveolin-1 and intercellular adhesion molecule-1 (ICAM-1), plays a crucial role in the development of protein-/neutrophil-rich pulmonary edema, the hallmark of ALI.
14p
viisaacnewton
26-04-2022
6
2
Download
-
Gene expression regulators identified in transcriptome profiling experiments may serve as ideal targets for genetic manipulations in farm animals. The Super deepSAGE technology and tissue-differential expression profiles are valuable resources for investigating the porcine gene expression regulation.
17p
vijeeni2711
24-07-2021
4
0
Download
-
The epidermal growth factor receptor (EGFR) family belongs to the transmembrane protein receptor of the tyrosine kinase I subfamily and has 4 members: EGFR/ERBB1, ERBB2, ERBB3, and ERBB4. The EGFR family is closely related to the occurrence and development of a variety of cancers.
14p
vianrose2711
27-04-2021
8
0
Download
-
Src homology 2 containing protein tyrosine phosphatase (PTP) 2 (Shp2) is a typical tyrosine phosphatase interacting with receptor tyrosine kinase to regulate multiple signaling pathways in diverse pathological processes. Here, we will investigate the effect of Shp2 inhibition on pulmonary arterial hypertension (PAH) in a rat model and its potential cellular and molecular mechanisms underlying.
10p
vimontana2711
05-04-2021
11
3
Download
-
ALK-rearrangement is observed in < 5% non-small cell lung cancer (NSCLC) cases and prior to the advent of oral tyrosine kinase inhibitors, the natural history of oncogenic NSCLC was typically poor. Literature relating to regression of treatment-naïve NSCLC is limited, and regression without treatment has not been noted in the ALK-rearranged sub-population.
9p
vimichigan2711
26-03-2021
15
2
Download
-
SPARC is a matricellular glycoprotein with growth-inhibitory and antiangiogenic activity in some cell types. The study of this protein in hematopoietic malignancies led to conflicting reports about its role as a tumor suppressor or promoter, depending on its different functions in the tumor microenvironment.
9p
vijisoo2711
29-09-2020
11
1
Download
-
Helicobacter pylori (H. pylori) and Epstein - Barr virus (EBV) plays a significant role in aggressive gastric cancer (GC). The investigation of genes associated with these pathogens and host kinases may be essential to understand the early and dynamic progression of GC.
14p
vijisoo2711
30-09-2020
18
0
Download
-
The EML4–ALK (echinoderm microtubule-associated protein-like 4 gene and the anaplastic lymphoma kinase gene) fusion oncogene represents a novel molecular target in a small subset of non–small–cell lung cancers (NSCLCs). The EML4–ALK fusion gene occurs generally in NSCLC without mutations in epidermal growth factor receptor (EGFR) and KRAS.
5p
vijennie2711
29-09-2020
10
0
Download
-
The expression of novel oncogenic kinase (NOK), a member of the protein tyrosine kinase (PTK) family, has been observed in several human malignancies including non-small cell lung cancer (NSCLC). However, the clinic relevance of NOK expression in NSCLC remains unclear.
7p
virose2711
22-09-2020
8
2
Download
-
The translocations of the anaplastic lymphoma kinase (ALK) gene with the echinoderm microtubuleassociated protein-like 4 (EML4) gene on chromosome 2p have been identified in non-small-cell lung cancers (NSCLCs) as oncogenic driver mutations.
10p
vilisa271
22-09-2020
15
0
Download
CHỦ ĐỀ BẠN MUỐN TÌM
![](images/graphics/blank.gif)